Showing results (2041-2050 of 10,003) with videos related to

Sort By:
Pageof 1,001
Leukemia & Lymphoma|March 22, 2016
Monokine induced by interferon gamma (MIG/CXCL9) is an independent prognostic factor in newly diagnosed myelomaArnold Bolomsky, Martin Schreder, Wolfgang Hübl, et al.
Leukemia & Lymphoma|April 29, 2016
Genetic aberrations in small B-cell lymphomas and leukemias: molecular pathology, clinical relevance and therapeutic targetsAgata M Bogusz, Adam Bagg
Leukemia & Lymphoma|April 29, 2016
Frequency and prognostic significance of t(v;11q23)/KMT2A rearrangements in adult patients with acute lymphoblastic leukemia treated with risk-adapted protocolsCristina Motlló, Josep-Maria Ribera, Mireia Morgades, et al.
Leukemia & Lymphoma|April 23, 2016
Validation of cutaneous lymphoma international prognostic index (CLIPI) for mycosis fungoides and Sézary syndromeHasan H Danish, Shuling Liu, Jaymin Jhaveri, et al.
Leukemia & Lymphoma|April 23, 2016
Differences between unselected patients and participants in multiple myeloma clinical trials in US: a threat to external validityLuciano J Costa, Parameswaran N Hari, Shaji K Kumar
Leukemia & Lymphoma|April 14, 2016
Effect of initial absolute monocyte count on survival outcome of patients with de novo non-M3 acute myeloid leukemiaJianhua Feng, Wei Zhang, Junqing Wu, et al.
Leukemia & Lymphoma|April 14, 2016
Negative impact of concurrent overexpression of MYC and BCL2 in patients with advanced diffuse large B-cell lymphoma treated with dose-intensified immunochemotherapyHiromichi Takahashi, Katsuhiro Miura, Masaru Nakagawa, et al.
Leukemia & Lymphoma|April 15, 2016
Indirect costs and workplace productivity loss associated with non-Hodgkin lymphomaJustin S Yu, Ryan N Hansen, Adriana Valderrama, et al.
Leukemia & Lymphoma|August 4, 2017
Can the SUVmax-liver-based interpretation improve prognostic accuracy of interim and posttreatment 18F-FDG PET/CT in patients with diffuse large B-cell lymphoma?Yuewei Zhang, Yang Fan, Zhitao Ying, et al.
Leukemia & Lymphoma|August 8, 2017
Myeloablative busulfan/cytoxan conditioning versus reduced-intensity fludarabine/melphalan conditioning for allogeneic hematopoietic stem cell transplant in patients with acute myelogenous leukemiaVishal Dhere, Scott Edelman, Edmund K Waller, et al.
Pageof 1,001